Skip to content
Sunday, November 8, 2026
Network Center UK

Providing Stem Cells During Pregnancy to Babies with Spina Bifida Improves Quality of Life, Trial Finds

A pioneering research effort has found that delivering regenerative cells to fetuses affected by spina bifida as part of a surgical repair may represent a "major milestone" in treating birth defects.

Study Parameters and Security

The US-based trial examined six developing infants with a severe neural tube defect. Doctors administered regenerative cells sourced from the maternal placenta directly onto the infant's spine while the defect was being closed.

Importantly, the cell therapy proved to be secure. Doctors verified that the therapy did not induce neoplasms, interfere with wound healing, or block the correction of associated brain abnormalities.

Encouraging Results

Post-birth MRI scans confirmed a successful correction of hindbrain herniation in every participant. This neurological improvement is a key indicator for better mobility and function.

"If it makes more children to achieve ambulation who previously could not, then it would become the conventional approach," noted the study director. "These findings are super exciting and open the door to a variety of prospective innovative interventions."

Future Implications and Hope

Experts not involved in the trial indicated that additional validation of these observed advantages could announce a "different age" in in-utero treatment. The potential to improve neural deficits occurring during fetal development is considered a revolutionary objective.

Notably important would be better management of urogenital and gastrointestinal outcomes, which are frequent complications for individuals living with this defect.

The Path Forward

Despite this being a first-in-human effort involved a limited number of patients, its established security and encouraging indicators provide a strong foundation for expanded clinical research. The addition of cellular treatment with established fetal surgery techniques presents significant potential for changing life trajectories for infants diagnosed prenatally with this neural tube defect.

TP
The writer

Todd Pruitt

Alexandra Reed is a seasoned network engineer and tech writer, passionate about demystifying complex technologies for everyday readers.

Network Center UK

Type to search articles.